News
News from Holden
Filter by:
Advice for all ages on colorectal cancer
More and more people across the country are finding themselves affected by colorectal ca
Melanoma vaccine trial to start at UI
Trial will test whether a personalized mRNA vaccine combined with an immunotherapy prevents melanoma from recurring
New radiation therapy targets tumors more precisely
Software piloted at UI Health Care increases precision of MR-Linac technology UI Health Care is the f
Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy
Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.
Dorfman Award Nominations
November 16, 2023 To: Holden Comprehensive Cancer Center Members
Holden oncologist receives NCI award for dedication to lung cancer clinical research
Muhammad Furqan, MD, medical oncologist in the University of Iowa Holden Comprehensive Cancer Center, is the recipie
Faculty awarded 2023 ACS seed grant through Holden Comprehensive Cancer Center
Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Researc
Is CAR T-cell therapy the future of cancer treatment?
University of Iowa Holden Comprehensive Car